Division of Systems Biology, National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas, United States of America.
PLoS One. 2013 Apr 23;8(4):e60368. doi: 10.1371/journal.pone.0060368. Print 2013.
Interindividual variability in the expression of drug-metabolizing enzymes and transporters (DMETs) in human liver may contribute to interindividual differences in drug efficacy and adverse reactions. Published studies that analyzed variability in the expression of DMET genes were limited by sample sizes and the number of genes profiled. We systematically analyzed the expression of 374 DMETs from a microarray data set consisting of gene expression profiles derived from 427 human liver samples. The standard deviation of interindividual expression for DMET genes was much higher than that for non-DMET genes. The 20 DMET genes with the largest variability in the expression provided examples of the interindividual variation. Gene expression data were also analyzed using network analysis methods, which delineates the similarities of biological functionalities and regulation mechanisms for these highly variable DMET genes. Expression variability of human hepatic DMET genes may affect drug-gene interactions and disease susceptibility, with concomitant clinical implications.
个体间药物代谢酶和转运体 (DMET) 的表达差异可能导致个体间药物疗效和不良反应的差异。已发表的分析 DMET 基因表达变异性的研究受到样本量和所分析基因数量的限制。我们系统地分析了 374 个 DMET 基因的表达情况,这些基因的表达谱来自于 427 个人肝样本的基因表达谱。DMET 基因的个体间表达标准差远高于非 DMET 基因。表达变异最大的 20 个 DMET 基因提供了个体间变异性的实例。还使用网络分析方法分析了基因表达数据,该方法描绘了这些高度可变的 DMET 基因的生物学功能和调节机制的相似性。人类肝脏 DMET 基因的表达变异性可能会影响药物-基因相互作用和疾病易感性,并具有相应的临床意义。